ERROL B DESOUZA

CIK 1213895 · CEO · last filed 2025-06-12

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$9.35M

Companies

7

Total Filings

79

Lifetime Open-Market Net

$33.4K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ALEC Director 69,950 $1.53 $107.0K $0 2 2025-06-12
RPRX Director 81,352 $54.87 $4.46M $0 7 2025-05-14
CYCN Director 50,000 $3.25 $162.5K $0 3 2023-12-04
CBIO Director 29,801 $17.92 $534.0K $0 20 2021-10-05
ALBIREO PHARMA, INC. (BIOD) Delisted CEO 159,416 $33.4K 18 2015-10-02
PTN Director $13.61 $0 4 2010-07-23
IDXX Director 7,276 $560.88 $4.08M $0 13 2009-05-01

Recent Filings · Page 2 of 8

79 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-06-29 RPRX Grant (A) +5,726 $0 EDGAR
2021-06-28 CYCN Grant (A) $0 EDGAR
2021-04-05 CBIO Grant (A) +2,926 $0 EDGAR
2021-01-06 CBIO Grant (A) +2,129 $0 EDGAR
2020-10-02 CBIO Grant (A) +3,125 $0 EDGAR
2020-09-23 RPRX Grant (A) +8,929 $0 EDGAR
2020-07-02 CBIO Grant (A) +2,129 $0 EDGAR
2020-06-17 RPRX Grant (A) +35,715 $0 EDGAR
2020-06-12 CBIO Grant (A) $0 EDGAR
2020-04-03 CBIO Grant (A) +2,860 $0 EDGAR
Showing 1120 of 79
Page 2 of 8
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.